In thymic carcinomas, mutations were found in genes involved in the histone modification pathway, including BAP1 (6%), SETD2 (11%), ASXL1 (4%), and in chromatin remodeling genes, such as SMARCA4 (4%). This evidence concerns the gene ASXL1 and thymic carcinoma.